echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Tibet's pharmaceutical industry fell last week's gains in a day, the funds off the market can pull off the storm?

    Tibet's pharmaceutical industry fell last week's gains in a day, the funds off the market can pull off the storm?

    • Last Update: 2020-10-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Text . . . Before the cephalosporine festival, the three major indexes in early trading volatility weakened, the market active funds have left the market, turnover continued to wilt, individual stocks fell, down more than 9% of nearly 40 stocks, short-term popularity continued to freeze.
    midday close, the Shanghai index was down 0.22 per cent at 3,212, the Shenzhen composite index was down 0.43 per cent at 12,759 and the GEM index was down 0.81 per cent at 2,519.
    net outflow of 759 million shares in Shanghai and 0.51 billion in Shenzhen.
    on the face of the market, the pharmaceutical industry vaccine sector continued to fall drag down the GEM index, with the European outbreak rebound is obvious, vaccine research and development progress smoothly in the market industry.
    vaccine development, Canada joins the Global Access mechanism for new crown vaccines (COVAX), China is expected to supply WHO with new crown vaccines, Johnson and Johnson new crown vaccines will start clinical Phase III trials, Novavax will begin clinical Phase III trials, and the European Union is scheduled to offer AstraZeneta's cheap new crown vaccine. The top five stocks in
    stocks last week were Zhengchuan (38.56%), Bo Yan Innovation (32.30%), Inte Group (26.00%), Saisheng Pharmaceuticals (23.64%) and Tibet Pharmaceuticals (14.42%), which are also significantly different from today's capital market performance.
    most notable is that since May 25 this year, the Long-standing Tibetan pharmaceutical industry, the stock price suddenly ushered in an explosion.
    to August 3, it reached an all-time high of 171.29 yuan per share.
    but Shengji's decline in Tibet's pharmaceutical industry has also ushered in a month-long decline, with a lowest price of 72.93 yuan per share and a market value of nearly 60%.
    last month, Tibet's pharmaceutical industry has made the dragon and tiger list 0 times, indicating that Tibet's pharmaceutical stocks have shown a very inactive state.
    but the first half of the year data are available, operating income of 628.55 million yuan, net profit attributable to shareholders of the parent company of 219.91 million yuan, an increase of 39.76 percent year-on-year.
    today (9.28), after last week's 14.23 per cent gain, most investors are trying to bottom out, with the afternoon of 14:17 again ushered in a halt, stunned everyone.
    And deep behind, with the disclosure of the half-yearly reports of listed companies, in Tibet pharmaceutical industry layout losses of the vast majority of the funds undoubtedly flowed to the wallet of private equity tycoon Ge Weidong, its position movement in admirable at the same time, but also let some of the investment really hate.
    rough estimate, not only tibet's pharmaceutical industry, in the first half of the year he earned nearly 4 billion yuan from (with You Network, Zhao Yi Innovation, Science and Technology News Fly, Ruike Laser, Tibet Pharmaceuticals).
    and the layout time is earlier, long-term holding.
    ,000-year-old Tibetan pharmaceutical company, is the only pharmaceutical stock in Ge Weidong's heavy warehouse.
    , according to Ge Weidong, capital market investment, he pays more attention to value investment, tend to buy a huge market space for individual stocks.
    whether or not its investment philosophy is of reference to ordinary investors, at least two points are explained: 1. Good business and development status is only a prerequisite, more importantly, the unilateral operation of investors.
    . Long-term investment in the capital market is not inferior to short-term, at least in grasping the laws of the market, after taking a long-term view, short-term profits are not so important.
    can only get a good return if you can get through it at some time.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.